Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uproleselan + Chemotherapy in Older Adults With Acute Myeloid Leukemia
NCT03701308Phase 3Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Mar 2019
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of uproleselan in acute myeloid leukemia (AML), sponsored by National Cancer Institute. Started Mar 2019; status: active, not recruiting.
02
Drugs
uproleselan
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03701308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03701308.